Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
At close: March 3 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-15,154
-13,716
-11,642
-15,053
Investing Cash Flow
15,555
15,540
924
14,757
Financing Cash Flow
1,300
7,822
9,898
1,068
End Cash Position
3,597
11,825
1,581
2,401
Capital Expenditure
-50
-65
-41
-441
Issuance of Capital Stock
--
3,983
5,810
--
Issuance of Debt
--
--
--
1,038
Repayment of Debt
-76
-63
--
--
Free Cash Flow
-15,204
-13,781
-11,683
-15,494
12/31/2021 - 10/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ETBI Eastgate Biotech Corp.
0.0045
+4,400.01%
MDCLF MedinCell S.A.
6.98
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
HOPHF Hemogenyx Pharmaceuticals Plc
1.2400
0.00%
ELDN Eledon Pharmaceuticals, Inc.
4.0050
-3.49%
DMAC DiaMedica Therapeutics Inc.
6.21
-4.90%
SCPX Scorpius Holdings, Inc.
0.1599
-6.49%
RZLT Rezolute, Inc.
4.1400
-6.55%
PULM Pulmatrix, Inc.
7.79
-3.59%
ATHE Alterity Therapeutics Limited
3.6400
-7.38%